A team at the Montreal Neurological Institute and Hospital – the Neuro – has been helping patients suffering from terminal neurological diseases. The Susan Cameron Cook Neuro-Palliative Care Program ...

Sydney, Australia, 28 November 2024 – Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, has completed one of the largest Series A ...

A team from IIT-BHU is developing a revolutionary cell-based device using 3D bioprinting technology to potentially cure ...

Poor balance and coordination are prominent features of Friedreich’s ataxia (FRDA). Czech researchers found that neuropsychiatric symptoms are also common among patients with FRDA.

At Lenovo Tech World '24, global technology leader Lenovo and the Scott-Morgan Foundation (SMF), a non-profit pioneering innovative assistive tech, revealed an AI-powered solution for people with ...

The announcement means the company will be pulling the plug on the CardinALS trial after its amyotrophic lateral sclerosis ...

Bank of America Securities analyst Tazeen Ahmad maintained a Sell rating on PTC Therapeutics (PTCT – Research Report) yesterday and set a price ...

While speaking during a conference, Giancarlo Comi suffered a sudden illness. The Italian luminary of neurology has died. He ...

Widetrial is supporting an expanded access program (EAP) to bring MN-166 (ibudilast) to ALS patients ineligible for clinical ...

PTC Therapeutics may reeling from the failure of its amyotrophic lateral sclerosis (ALS) drug utreloxastat yesterday, but the ...

A biotech start-up that has shown the ability to pause and in some cases reverse neurodegenerative diseases in mice has ...

PTC Therapeutics' Phase II trial for utreloxastat in ALS failed to meet its primary endpoint, showing no significant ...